358 Ramucirumab in combination with pembrolizumab as first-line treatment for recurrent or metastatic head and neck squamous-cell carcinoma: a phase 1–2 trial

• Peter Oppelt,
• Jingxia Liu,
• Douglas Adkins,
• Jessica Ley,
• Kevin Palka,
• Miriam Jacobs

Affiliations

Peter Oppelt

Department of Obstetrics, Johannes Kepler University Linz, Linz, Austria

Jingxia Liu

Division of Biostatistics, Washington University School of Medicine, St Louis, MO.

Douglas Adkins

Washington University School of Medicine, St. Louis, MO, USA

Jessica Ley

Washington University School of Medicine, St. Louis, MO, USA

Kevin Palka

Washington University School of Medicine, St. Louis, MO, USA

Miriam Jacobs

Washington University School of Medicine, St. Louis, MO, USA